Registry-listed formulations

This catalogue entry has no confirmed scientific concept.

Each study is counted once in the molecule profile. Registry products remain separate. Naming an ingredient does not establish that products are interchangeable or what participants received.

1 source entries across 1 studies. This list may not include all unresolved or historical entries.

  • Standard iNO therapyRegistry intervention

    Linked study entry; product equivalence not established

    View study and source

Success Metrics

Completion Rate
0%(0/1)
Active Trials
0(0%)
Terminated
1(100%)

Phase Distribution

Phase 3
1
100%

Phase Distribution

0

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution1 total trials
Phase 3Large-scale testing
1(100.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

0.0%

0 of 1 finished

Non-Completion Rate

100.0%

1 ended early

Currently Active

0

trials recruiting

Total Trials

1

all time

Status Distribution
Terminated(1)

Detailed Status

Terminated1

Development Timeline

Analytics

Development Status

Total Trials
1
Active
0
Success Rate
0.0%
Most Advanced
Phase 3

Trials by Phase

Phase 31 (100.0%)

Trials by Status

terminated1100%

Recent Activity

0 active trials
Showing 1 of 1
terminatedphase_3

Early Inhaled Nitric Oxide for Respiratory Failure in Newborns

NCT00005773

Clinical Trials (1)

Showing 1 of 1 trials
NCT00005773Phase 3

Early Inhaled Nitric Oxide for Respiratory Failure in Newborns

Terminated

All 1 trials loaded

Drug Details

Intervention Type
Drug
Total Trials
1